大脑转移和下一代抗癌疗法:临床医生的生存指南
Angelo Dipasquale1, Chiara Barigazzi2, Agnese Losurdo2
1Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Critical reviews in oncology/hematology
|December 21, 2023
概括
新的抗癌疗法为脑转移 (BM) 患者提供了希望. 本综述指导医生使用向药物和免疫疗法治疗肺癌,乳腺癌,黑色素瘤和癌.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 从历史上看,大脑转移 (BMs) 具有有限的治疗选择和糟糕的患者结果.
- 新型治疗方法的出现,如分子向药物和免疫疗法,已经改变了BMs的管理.
- 这些进步为BM护理中的临床决策带来了新的复杂性.
研究的目的:
- 审查目前关于检查点抑制剂和针对性治疗的证据.
- 为管理 BM 的临床医生提供实际指导和潜在的工作流程.
- 讨论BMs治疗和研究中的当前和未来的挑战.
主要方法:
- 系统审查目前关于 BMs 系统疗法的证据.
- 专注于特定的癌症类型:肺癌,乳腺癌,黑色素瘤和细胞癌.
- 讨论包括临床试验设计和中枢神经系统药物透在内的挑战.
主要成果:
- 检查点抑制剂和向疗法在管理BM中表现有前途.
- 证据支持在特定的BM患者群体中使用它们,特别是在肺,乳腺,黑色素瘤和细胞癌中.
- 更好地了解BMs的分子特征对于治疗疗效至关重要.
结论:
- 医生需要更新的指导来导航BMs复杂的治疗决策.
- 新型疗法正在改善结果,但药物输送和试验设计方面的挑战仍然存在.
- 本综述作为指南,以加强BMs的临床决策.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:30Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370